Modern metabolic dysfunction often begins with exaggerated insulin responses that lock the body into fat-storage mode. Russell Clark’s clinical protocols target these spikes through precise hormonal timing, targeted nutrition, and strategic use of dual-incretin therapies. This guide synthesizes the latest research on insulin dynamics, incretin biology, and sustainable fat loss while answering the most common questions patients ask.
Understanding Insulin Spikes and Metabolic Adaptation
Insulin is the body’s primary anabolic hormone, directing glucose into cells and signaling fat storage. Repeated high-glycemic meals create chronic spikes that desensitize tissues, elevate HOMA-IR scores, and promote visceral fat accumulation. As fat mass increases, leptin sensitivity declines, muting the brain’s “I am full” signal and driving hidden hunger despite adequate calories.
Clark’s approach rejects the outdated CICO model. Instead, it prioritizes food quality, meal timing, and mitochondrial efficiency. By lowering systemic inflammation—measured via hs-CRP—patients restore insulin sensitivity and mitochondrial function. Efficient mitochondria convert fatty acids into ATP with minimal ROS, sustaining energy without glucose crashes. Research consistently shows that even modest reductions in postprandial insulin correlate with improved body composition and long-term weight maintenance.
The Power of Incretins: GLP-1 and GIP
GLP-1 and GIP are gut-derived hormones that orchestrate post-meal metabolism. GLP-1 slows gastric emptying, suppresses glucagon, and activates brain satiety centers. GIP enhances insulin secretion in a glucose-dependent manner while influencing lipid metabolism and central appetite regulation. Dual agonists like tirzepatide leverage both pathways, producing superior weight loss compared to GLP-1 monotherapy.
Clinical data reveal that combining these incretins improves insulin sensitivity, reduces inflammatory markers, and supports lean mass preservation. Clark integrates low-dose tirzepatide within a structured 30-week metabolic reset. This avoids lifelong dependency by cycling the medication alongside dietary interventions that naturally boost endogenous incretin release.
The 70-Day CFP Weight Loss Protocol
Clark’s CFP protocol unfolds in distinct phases designed to retrain metabolic flexibility. Phase 2 (Aggressive Loss) spans 40 days of lectin-free, low-carbohydrate eating paired with low-dose tirzepatide. Eliminating lectins reduces gut permeability and lowers CRP, quieting the inflammatory “fire” that traps fat. Meals emphasize nutrient-dense, low-lectin vegetables such as bok choy, high-quality proteins, and moderate berries to maximize vitamins per calorie while minimizing insulin demand.
The subsequent Maintenance Phase (final 28 days) stabilizes the new weight set point. Patients transition to higher carbohydrate cycling around workouts to replenish glycogen without reigniting spikes. Resistance training during both phases protects muscle mass, directly supporting BMR. Bioimpedance or DEXA monitoring ensures improvements in true body composition rather than scale weight alone.
Red light therapy is layered in to enhance mitochondrial efficiency, further accelerating fat oxidation and ketone production. Elevated ketones provide steady brain fuel, blunt hunger, and exert anti-inflammatory effects that reinforce leptin sensitivity.
Anti-Inflammatory Nutrition and Mitochondrial Repair
An anti-inflammatory protocol forms the foundation. Removing refined carbohydrates, industrial seed oils, and high-lectin foods rapidly lowers CRP and restores cellular signaling. Nutrient density becomes the guiding principle—patients consume voluminous, fiber-rich meals that satisfy the brain’s micronutrient sensors and prevent compensatory overeating.
Mitochondrial health receives equal focus. Supporting cofactors such as vitamin C, strategic fasting windows, and red light exposure improve electron transport chain efficiency. The result is higher basal metabolic rate, better fat utilization, and sustained energy. Research links these cellular improvements to measurable drops in HOMA-IR and enhanced insulin sensitivity that persist beyond active treatment.
Subcutaneous injections of tirzepatide are administered with precise site rotation to ensure consistent absorption and minimize local reactions. Patients learn to align injection timing with their circadian rhythm and meal schedule for optimal incretin synergy.
Common Questions: What the Research Says
How quickly can I expect insulin sensitivity to improve? Studies on dual incretin therapies show clinically meaningful HOMA-IR reductions within 4–8 weeks when combined with carbohydrate restriction. Clark’s patients frequently report normalized fasting insulin by the end of the 40-day aggressive phase.
Will I lose muscle on this protocol? Emphasis on resistance training, adequate protein, and strategic carbohydrate refeeds around workouts preserves lean mass. Body composition data consistently demonstrate fat-specific loss while BMR remains stable or increases.
Is lifelong medication required? The 30-week tirzepatide reset is intentionally finite. By the end, restored leptin sensitivity, lowered inflammation, and ingrained low-insulin eating habits allow most patients to maintain results without ongoing pharmacotherapy.
Are ketones necessary for success? While not mandatory, nutritional ketosis accelerates fat oxidation and provides neuroprotective effects. Many experience mental clarity and appetite suppression once adapted.
How does bok choy fit into the plan? Its exceptional nutrient density, negligible lectin content, and low carbohydrate profile make it a staple. Rich in glucosinolates and antioxidants, it supports detoxification and keeps meals satisfying during caloric cycling.
Practical Steps to Begin Your Metabolic Reset
Start by tracking baseline hs-CRP, fasting insulin, and body composition. Adopt a lectin-free, nutrient-dense template for two weeks to lower inflammation before introducing medication. Incorporate daily resistance training and morning red light sessions. Time any tirzepatide injections consistently and monitor ketones periodically to gauge metabolic flexibility.
Focus on consistency rather than perfection. Each insulin-sparing meal, strength session, and anti-inflammatory choice compounds into restored hormonal signaling. Patients following Clark’s framework routinely achieve 15–25 % body fat reduction within one 70-day cycle while reporting dramatically improved energy, mood, and hunger control.
The path to optimized insulin dynamics is not about deprivation but strategic biological alignment. By addressing root causes—inflammation, mitochondrial inefficiency, and incretin imbalance—sustainable fat loss becomes the natural byproduct of a repaired metabolism.